BMY logo

BMY Bristol-Myers Squibb Company

New York Stock Exchange · Drug Manufacturers - General · Healthcare

$58.80
+0.46 (+0.79%)

Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceu…

Market Cap: $120.19Bwww.bms.com

Price

$62.80-7.54%
$56.67$60.48$64.28$68.09
Aug 25Nov 10

Social Signal Score

50
5d
51
7 mentions
+0.0%
30d
47
38 mentions
+2.1%
60d
50
82 mentions
+2.7%
90d
51
108 mentions
-6.7%
news: 97 · marketaux: 3 · rss: 8

Analyst Ratings

42 analysts
Holdconsensus
Strong Buy 0Buy 19Hold 21Sell 2Strong Sell 0
Avg price target$66.14+12.5%
Low $41Median $66High $78
Current Consensus

52-week range

$45.79$68.09
Last close
$62.80
Off 52w high
-7.8%
200-day average
$60.22
vs 200-day
+4.3%

Revenue

$13.07B+149.27%
$4.93B$7.64B$10.36B$13.07B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$6.11
$5.94–$6.51
18 analysts
FY2026
$6.45+6% YoY
$6.18–$6.57
16 analysts
FY2027
$6.70+4% YoY
$6.13–$7.24
17 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Christopher Boerner
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
32,500
Beta
0.23
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
2.63
www.bms.com